BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34122565)

  • 1. Pulse-dose-rate interstitial brachytherapy in anal squamous cell carcinoma: clinical outcomes and patients' health quality perception.
    Bourdais R; Achkar S; Espenel S; Bockel S; Chauffert-Yvart L; de Mellis FR; Ta MH; Boukhelif W; Durand-Labrunie J; Burtin P; Haie-Meder C; Deutsch E; Chargari C
    J Contemp Brachytherapy; 2021 Jun; 13(3):263-272. PubMed ID: 34122565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interstitial pulsed-dose-rate brachytherapy for the treatment of squamous cell anal carcinoma: A retrospective single institution analysis.
    Boukhelif W; Ferri-Molina M; Mazeron R; Maroun P; Duhamel-Oberlander AS; Dumas I; Martinetti F; Guemnie-Tafo A; Chargari C; Haie-Meder C
    Brachytherapy; 2015; 14(4):549-53. PubMed ID: 25935731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcome after treatment with a brachytherapy boost versus external beam boost for anal carcinoma.
    Oehler-Jänne C; Seifert B; Lütolf UM; Studer G; Glanzmann C; Ciernik IF
    Brachytherapy; 2007; 6(3):218-26. PubMed ID: 17681244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerance of high-dose-rate brachytherapy boost after external radiotherapy in the treatment of squamous cell carcinoma of the anal canal.
    Bertin E; Benezery K; Kee DLC; François E; Evesque L; Gautier M; Gerard JP; Hannoun-Levi JM; Falk AT
    J Contemp Brachytherapy; 2018 Dec; 10(6):522-531. PubMed ID: 30662475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twenty-year experience in the management of squamous cell anal canal carcinoma with interstitial brachytherapy.
    López Guerra JL; Lozano AJ; Pera J; Gutiérrez C; Cambray M; Ferrer F; Guedea F
    Clin Transl Oncol; 2011 Jul; 13(7):472-9. PubMed ID: 21775274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term results of chemoradiation plus pulsed-dose-rate brachytherapy boost in anal canal carcinoma: A mono-institutional retrospective analysis.
    Arcelli A; Buwenge M; Macchia G; Cammelli S; Deodato F; Cilla S; Galuppi A; Panni V; Mattiucci GC; Tagliaferri L; Morganti AG
    J Contemp Brachytherapy; 2019 Feb; 11(1):21-27. PubMed ID: 30911306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PDR brachytherapy with flexible implants for interstitial boost after breast-conserving surgery and external beam radiation therapy.
    Fritz P; Berns C; Anton HW; Hensley F; Assman J; Flentje M; von Fournier D; Wannenmacher M
    Radiother Oncol; 1997 Oct; 45(1):23-32. PubMed ID: 9364628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of High Dose Rate Interstitial Implant on Early and Locally Advanced Oral Cavity Cancers: Update and Long-Term Follow-Up Study.
    Vedasoundaram P; Raghava Ks A; Periasamy K; Selvarajan G; K S; Kandasamy S; R S; Kumar A
    Cureus; 2020 May; 12(5):e7910. PubMed ID: 32494525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long term results of a prospective dose escalation phase-II trial: interstitial pulsed-dose-rate brachytherapy as boost for intermediate- and high-risk prostate cancer.
    Lettmaier S; Lotter M; Kreppner S; Strnad A; Fietkau R; Strnad V
    Radiother Oncol; 2012 Aug; 104(2):181-6. PubMed ID: 22853851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose-rate interstitial brachytherapy boost for the treatment of anal canal cancers.
    Cordoba A; Escande A; Leroy T; Mirabel X; Coche-Dequéant B; Lartigau E
    Brachytherapy; 2017; 16(1):230-235. PubMed ID: 27600606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interstitial high-dose rate brachytherapy as boost for anal canal cancer.
    Falk AT; Claren A; Benezery K; François E; Gautier M; Gerard JP; Hannoun-Levi JM
    Radiat Oncol; 2014 Nov; 9():240. PubMed ID: 25377886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two fractions of high-dose-rate brachytherapy in the management of cervix cancer: clinical experience with and without chemotherapy.
    Sood BM; Gorla G; Gupta S; Garg M; Deore S; Runowicz CD; Fields AL; Goldberg GL; Anderson PS; Vikram B
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):702-6. PubMed ID: 12062615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Definitive Radiotherapy for Primary Squamous Cell Carcinoma of the Vagina: Are High-Dose External Beam Radiotherapy and High-Dose-Rate Brachytherapy Boost the Best Treatment? Experience of Two Italian Institutes.
    Laliscia C; Gadducci A; Fabrini MG; Barcellini A; Guerrieri ME; Parietti E; Ursino S; Morganti R; Cafaro I; Paiar F
    Oncol Res Treat; 2017; 40(11):697-701. PubMed ID: 29065399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interstitial brachytherapy as a boost to patients with anal carcinoma and poor response to chemoradiation: Single-institution long-term results.
    Gryc T; Ott O; Putz F; Knippen S; Raptis D; Fietkau R; Strnad V
    Brachytherapy; 2016; 15(6):865-872. PubMed ID: 27720203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer.
    Niehoff P; Dietrich J; Ostertag H; Schmid A; Kohr P; Kimmig B; Kovács G
    Strahlenther Onkol; 2006 Feb; 182(2):102-7. PubMed ID: 16447017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of definitive irradiation in a series of 305 epidermoid carcinomas of the anal canal.
    Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Houry S; Gallot D; Parc R; Huang R; Qu SH; Huart J; Pène F; Schlienger M
    Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1259-73. PubMed ID: 12873670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulsed low dose rate brachytherapy for uterine cervix carcinoma.
    Rogers CL; Freel JH; Speiser BL
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):95-100. PubMed ID: 9989519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brachytherapy as part of the conservative treatment for primary and recurrent vulvar carcinoma.
    Castelnau-Marchand P; Escande A; Mazeron R; Bentivegna E; Cavalcanti A; Gouy S; Baratiny C; Maroun P; Morice P; Haie-Meder C; Chargari C
    Brachytherapy; 2017; 16(3):518-525. PubMed ID: 28262516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
    Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
    Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protocol-based image-guided salvage brachytherapy. Early results in patients with local failure of prostate cancer after radiation therapy.
    Lahmer G; Lotter M; Kreppner S; Fietkau R; Strnad V
    Strahlenther Onkol; 2013 Aug; 189(8):668-74. PubMed ID: 23824103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.